SEC Form 4 · Updated Daily
ARPO
Insider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| NOVARTIS AG | 10%+ Owner | 4,049,804 | 2019-04-26 | S |
| Novartis Bioventures Ltd | 10%+ Owner | 4,049,804 | 2019-04-26 | S |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2019-04-26 | NOVARTIS AG | Open-market sale | 138,704 | $1.03 | 4,049,804 |
| 2019-04-26 | Novartis Bioventures Ltd | Open-market sale | 138,704 | $1.03 | 4,049,804 |
| 2019-04-25 | NOVARTIS AG | Open-market sale | 563,096 | $1.03 | 4,188,508 |
| 2019-04-25 | Novartis Bioventures Ltd | Open-market sale | 563,096 | $1.03 | 4,188,508 |
| 2019-04-24 | NOVARTIS AG | Open-market sale | 16,403 | $1.03 | 4,751,604 |
| 2019-04-24 | Novartis Bioventures Ltd | Open-market sale | 16,403 | $1.03 | 4,751,604 |
| 2019-04-23 | NOVARTIS AG | Open-market sale | 27,554 | $1.03 | 4,768,007 |
| 2019-04-23 | Novartis Bioventures Ltd | Open-market sale | 27,554 | $1.03 | 4,768,007 |
| 2019-04-22 | NOVARTIS AG | Open-market sale | 7,100 | $0.97 | 4,795,561 |
| 2019-04-22 | Novartis Bioventures Ltd | Open-market sale | 7,100 | $0.97 | 4,795,561 |
| 2019-04-15 | NOVARTIS AG | Open-market sale | 28,794 | $0.99 | 4,802,661 |
| 2019-04-15 | Novartis Bioventures Ltd | Open-market sale | 28,794 | $0.99 | 4,802,661 |
| 2019-04-12 | NOVARTIS AG | Open-market sale | 30,908 | $1.04 | 4,831,455 |
| 2019-04-12 | Novartis Bioventures Ltd | Open-market sale | 30,908 | $1.04 | 4,831,455 |
| 2019-04-11 | NOVARTIS AG | Open-market sale | 57,438 | $1.08 | 4,862,363 |
| 2019-04-11 | Novartis Bioventures Ltd | Open-market sale | 57,438 | $1.08 | 4,862,363 |
| 2019-04-10 | NOVARTIS AG | Open-market sale | 140,230 | $1.09 | 4,919,801 |
| 2019-04-10 | Novartis Bioventures Ltd | Open-market sale | 140,230 | $1.09 | 4,919,801 |
| 2019-04-09 | NOVARTIS AG | Open-market sale | 32,991 | $1.01 | 5,060,031 |
| 2019-04-09 | Novartis Bioventures Ltd | Open-market sale | 32,991 | $1.01 | 5,060,031 |
| 2019-04-08 | NOVARTIS AG | Open-market sale | 27,525 | $1.02 | 5,093,022 |
| 2019-04-08 | Novartis Bioventures Ltd | Open-market sale | 27,525 | $1.02 | 5,093,022 |
| 2019-04-05 | NOVARTIS AG | Open-market sale | 24,661 | $1.02 | 5,120,547 |
| 2019-04-05 | Novartis Bioventures Ltd | Open-market sale | 24,661 | $1.02 | 5,120,547 |
| 2019-04-04 | NOVARTIS AG | Open-market sale | 47,900 | $1.01 | 5,145,208 |
| 2019-04-04 | Novartis Bioventures Ltd | Open-market sale | 47,900 | $1.01 | 5,145,208 |
| 2019-04-03 | NOVARTIS AG | Open-market sale | 58,033 | $0.96 | 5,193,108 |
| 2019-04-03 | Novartis Bioventures Ltd | Open-market sale | 58,033 | $0.96 | 5,193,108 |
| 2019-04-02 | NOVARTIS AG | Open-market sale | 51,754 | $0.97 | 5,251,141 |
| 2019-04-02 | Novartis Bioventures Ltd | Open-market sale | 51,754 | $0.97 | 5,251,141 |
| 2019-04-01 | NOVARTIS AG | Open-market sale | 116,909 | $0.95 | 5,302,895 |
| 2019-04-01 | Novartis Bioventures Ltd | Open-market sale | 116,909 | $0.95 | 5,302,895 |
| 2019-03-29 | NOVARTIS AG | Open-market sale | 63,100 | $0.91 | 5,419,804 |
| 2019-03-29 | Novartis Bioventures Ltd | Open-market sale | 63,100 | $0.91 | 5,419,804 |
| 2019-03-28 | NOVARTIS AG | Open-market sale | 88,835 | $0.94 | 5,482,904 |
| 2019-03-28 | Novartis Bioventures Ltd | Open-market sale | 88,835 | $0.94 | 5,482,904 |
| 2019-03-27 | NOVARTIS AG | Open-market sale | 50,749 | $0.99 | 5,571,739 |
| 2019-03-27 | Novartis Bioventures Ltd | Open-market sale | 50,749 | $0.99 | 5,571,739 |
| 2019-03-26 | NOVARTIS AG | Open-market sale | 177,762 | $1.01 | 5,622,488 |
| 2019-03-26 | Novartis Bioventures Ltd | Open-market sale | 177,762 | $1.01 | 5,622,488 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.